News

September Highlight: Identifying and Managing Moderate and Severe TD

09/29/2021

Popular Now

Videos

01/05/2018

Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.

Psych Congress co-chair Rakesh...

01/05/2018

Psychiatry & Behavioral Health

News

FDA Approves First Schizophrenia Treatment in Over 3 Decades

09/27/2024

Meagan Thistle ;

The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.

The US Food and Drug...

09/27/2024

Psych Congress Network

BHE Podcast

BHE Podcast, Episode 029 – Lisa Richardson, Beyond Healthcare CEO

07/29/2022

Lisa Richardson, CEO and co-founder of Beyond Healthcare, discusses the importance of connection and community, both in caring for clients and their families, as well as for building a healthy workplace for staff.

Lisa Richardson, CEO and...

07/29/2022

Behavioral Healthcare Executive

News

Elizabeth Smart: The Story Beyond the Trauma

12/02/2021

Heather Flint, Senior Digital Managing Editor

Elizabeth Smart gives a moving and emotional keynote address about her journey after trauma.

Elizabeth Smart gives a moving...

12/02/2021

Psych Congress Network

Podcasts

The Link Between Lithium Use and Tardive Dyskinesia

12/29/2021

Dr Joseph Goldberg provides information on how lithium use for bipolar disorder can cause tardive dyskinesia and how to correctly identify and address this problem.

September Highlight: Identifying and Managing Moderate and Severe TD

Popular Now

Sign Up

Specialties

Events

Year Round Education

HMP Global Products